TY - JOUR
T1 - Crystallinity of covalent organic frameworks controls immune responses
AU - Esrafili, Arezoo
AU - Thumsi, Abhirami
AU - Jaggarapu, Madhan Mohan Chandra Sekhar
AU - Nile, Richard G.
AU - Kupfer, Joshua
AU - Dugoni, Margaret
AU - Suresh, Abhirami P.
AU - Khodaei, Taravat
AU - Qian, Huikang
AU - Mathis, Anna
AU - Kim, Brandon
AU - Swaminathan, Srivatsan J.
AU - Sun, Wei
AU - Seo, Yeo Weon
AU - Lintecum, Kelly
AU - Pathak, Sanmoy
AU - Tong, Xinbo
AU - Holloway, Julianne L.
AU - Jin, Kailong
AU - Acharya, Abhinav P.
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Biomaterials can act as pro- or anti-inflammatory agents. However, effects of biomaterials crystallinity on immune responses are poorly understood. We demonstrate that the adjuvant-like behaviour of covalent organic framework (COF) biomaterial is dependent on its crystallinity. COF crystallinity is inversely correlated with the activation of mouse and human dendritic cells (DC), but with antigen presentation by mouse DCs only. Amorphous COFs upregulates NFkB, TNF, and RIG-I signalling pathways, as well as the chemotaxis-associated gene Unc5c, when compared to crystalline COFs. Meanwhile, Unc5c inhibition disrupts the correlation between crystallinity and DC activation. Furthermore, COFs with the lowest crystallinity admixed with chicken ovalbumin (OVA) antigen prevent OVA-expressing B16F10 tumour growth in 60% of mice, with this protection associated with the induction of antigen-specific, pro-inflammatory T cell. The lowest crystalline COFs admixed with TRP2 antigen can also prevent non-immunogenic YUMM1.1 tumour growth in 50% of mice. These findings demonstrate that the crystallinity of biomaterials is an important aspect to consider when designing immunotherapy for pro- or anti-inflammatory applications.
AB - Biomaterials can act as pro- or anti-inflammatory agents. However, effects of biomaterials crystallinity on immune responses are poorly understood. We demonstrate that the adjuvant-like behaviour of covalent organic framework (COF) biomaterial is dependent on its crystallinity. COF crystallinity is inversely correlated with the activation of mouse and human dendritic cells (DC), but with antigen presentation by mouse DCs only. Amorphous COFs upregulates NFkB, TNF, and RIG-I signalling pathways, as well as the chemotaxis-associated gene Unc5c, when compared to crystalline COFs. Meanwhile, Unc5c inhibition disrupts the correlation between crystallinity and DC activation. Furthermore, COFs with the lowest crystallinity admixed with chicken ovalbumin (OVA) antigen prevent OVA-expressing B16F10 tumour growth in 60% of mice, with this protection associated with the induction of antigen-specific, pro-inflammatory T cell. The lowest crystalline COFs admixed with TRP2 antigen can also prevent non-immunogenic YUMM1.1 tumour growth in 50% of mice. These findings demonstrate that the crystallinity of biomaterials is an important aspect to consider when designing immunotherapy for pro- or anti-inflammatory applications.
UR - http://www.scopus.com/inward/record.url?scp=85209480633&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85209480633&partnerID=8YFLogxK
U2 - 10.1038/s41467-024-54227-9
DO - 10.1038/s41467-024-54227-9
M3 - Article
C2 - 39528477
AN - SCOPUS:85209480633
SN - 2041-1723
VL - 15
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 9739
ER -